Highlights
- Metropolis Healthcare is a midcap company with a market capitalization of Rs 17,302 crore.
- Over the past five years, its stock has posted an average increase of 15 per cent in its revenue and profits.
- This stock has given returns of 72.86 per cent to its investors on a year-on-year basis.
Metropolis Healthcare: Metropolis Healthcare is a medical laboratory operator company primarily based in Mumbai. It is a midcap company with a market capitalization of Rs 17,302 crore. The company has a strong financial position. It has registered good growth in revenue and profits year after year. Over the past five years, its stock has posted an average increase of 15 per cent in its revenues and profits. It shows that the management of the company is good.
Effect of agile management on stock prices
The kind of strong performance of the company is clearly visible in its share price. The stock has given returns of 72.86 per cent to its investors on a year-on-year basis. Also, the short-term performance of one month is quite good. During this period too, the company’s stock gave a return of around 11 per cent, despite the bearish sentiment in the market. During this too, it has outperformed many of its competitors.
what’s on the technical chart
On the technical chart, the stock is forming an ascending triangle-like pattern at the top which is a bullish signal. The stock has gained almost three per cent today and is trading near the breakout level of 3400. This is its all-time highest level. The RSI is indicating good strength at 60 and has entered the bullish zone. The trend indicator ADX at 30 shows good trend strength. Today’s price trend of the stock is supported by the bullish nature which proves the bullish nature of the stock.
what to expect next
The stock is very well poised to break out of its ascending triangle pattern. With strong price action and rising volumes, the stock is expected to hit new highs in the Uncharted Territory.
For more such content, subscribe to Dalal Street Investment Journal, India’s #1 equity research and investment magazine.
Disclaimer: This content is created by Dalal Street Investment Journal and Times Internet Limited (TIL) does not take any responsibility of any promise or claim. Please take all necessary steps to ensure that the content is correct, updated and verified.
.